New study tests best emergency breathing tube for trauma victims
NCT ID NCT04100564
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at over 2,000 trauma patients who needed help breathing before arriving at the hospital. Half were given a supraglottic airway device (like an LMA or King tube) first, while the other half received standard care. The goal was to see which approach led to more patients surviving the first 24 hours. The trial took place across 17 ambulance services and trauma centers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Supraglottic airway device (e.g., LMA, King, i-gel)
What this could lead to
If successful, this could establish a better standard for emergency airway management in trauma, potentially saving more lives within the first 24 hours.
What could go wrong
This is a completed trial, but results may not apply to all trauma settings or patient types. The intervention is a device, not a drug, so benefits may be modest and depend on paramedic training.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRAUMA INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Allegheny General Hospital
Pittsburgh, Pennsylvania, 15212, United States
-
East Carolina University
Greenville, North Carolina, 27835, United States
-
Emory University
Atlanta, Georgia, 30303, United States
-
John H. Stroger Hospital of Cook County
Chicago, Illinois, 60612, United States
-
Mount Sinai Hospital
Chicago, Illinois, 60608, United States
-
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
Tulane University
New Orleans, Louisiana, 70112, United States
-
UPMC
Pittsburgh, Pennsylvania, 15261, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Louisville
Louisville, Kentucky, 40208, United States
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
-
Vanderbilt University
Nashville, Tennessee, 37235, United States
-
Washington University at St. Louis
St Louis, Missouri, 63110, United States